PhosphoSolutions成立于2001年，由Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik 等一同创立，已发展成为在神经科学领域的蛋白及抗体的领先供应商。

PhosphoSolutions was founded in 2001 by Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik who all worked together in the laboratory of Dr. Paul Greengard, co-recipient of the 2000 Nobel Prize in Medicine for his work on the role of protein phosphorylation in signal transduction in the nervous system. This expertise has led us to focus primarily on proteins of interest in the neuroscience field.

PhosphoSolutions公司的主要产品包括：

Cardiovascular

Catecholamine Signaling

Cell Markers

Cytoskeletal and Nuclear Proteins

DNA Damage

Extracellular Matrix Proteins

GABA Receptors

Glutamate Receptors and Associated Signaling Proteins

Hormone Biosynthesis

Neurodegenerative Disease

Neurogenesis and Development

Neurotransmission

Oncoproteins

RNA Processing

Signal Transduction

Steroid Hormone Receptors

Synaptic Vesicle Proteins

Uncategorized

Visual System

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Epredia品牌。

Epredia是一家全球性公司，致力于实现精准癌症诊断，Epredia的产品组合代表了整个组织学工作流程，从标本采集到处理，从切片到染色，从成像到存档。Epredia由Shandon、Microm、Menzel Gläser和Richard-Allan Scientific等品牌组成，拥有广泛的解决方案，这些解决方案已经并将继续改变解剖病理学市场。

Epredia的解决方案包括：

（1）组织处理和包埋解决方案：随着新的工作环境和人员配备挑战的出现，了解组织处理试剂如何节省时间并提高处理组织的质量至关重要。

（2）标签和跟踪解决方案：PrintMate AS™盒式打印机和SlideMate幻灯片打印机系列，减少因标签错误而出错的机会，并通过自动化的方式标记和跟踪实验室样本和幻灯片来简化工作流程。

（3）组合解决方案：Epredia一直在寻找简化工作流程的方法，同时增强结果。

（4）存档解决方案：存档是实验室中确保整个组织学工作流程中样本安全的重要过程。